文献速递胸部肿瘤

肺癌筛查中的假阴性结果:证据与争议

False-Negative Results in Lung Cancer Screening-Evidence and Controversies.
PubMed 文献 · J Thorac Oncol · 2021-02-03

本文综述肺癌筛查中假阴性结果的影响与原因,涉及影像评估、结节管理方案及多学科团队决策。假阴性病例占所有筛查参与者比例不高,但可占筛查项目诊断肺癌的较高比例(高达15%)。文章讨论假阴性定义分类的争议及数据记录方式,并权衡避免过度监视与减少过度诊断的挑战。

要点

  • 假阴性可占筛查诊断肺癌的较高比例(高达15%),需重视。
  • 假阴性原因涉及影像评估、结节管理方案及多学科决策。
  • 需平衡避免过度监视与减少过度诊断及良性病变检查。

核心结论

  • 假阴性是肺癌筛查的重要质量指标,但其定义、分类和数据记录存在争议。

研究设计与样本

  • 本文为综述,基于国际筛查研究数据讨论假阴性肺癌筛查测试的影响、原因及争议。

主要发现

  • 假阴性病例占所有筛查参与者比例不高,但可占筛查项目诊断肺癌的较高比例(高达15%)。
  • 假阴性原因涉及影像评估、结节管理方案及多学科团队管理决策。

临床怎么用

  • 临床需关注假阴性风险,优化影像评估和结节管理,并平衡避免过度监视与减少过度诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Identifying false-negative cases is an important quality metric in lung cancer screening, but it has been infrequently and variably reported in previous studies. Although as a proportion of all screening participants, false-negative cases are uncommon, such cases may constitute a substantial proportion of all lung cancers diagnosed (up to 15%) within a screening program. This article reviews the impact and causes of false-negative lung cancer screening tests, including those related to radiologic evaluation, nodule management protocols, and management decisions made by multidisciplinary teams. Following a review of data from international screening studies, this article discusses the controversies within the screening literature surrounding the definition and classification of a false-negative lung cancer screening test and how data on false-negative rates should be captured and recorded. Challenges, such as avoiding overly cautious surveillance of lung nodules while minimizing overdiagnosis and investigation of indolent or benign lesions, are considered. Finally, the advantages and disadvantages of different approaches to dealing with false-negative results in lung cancer screening are discussed.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Bartlett EC, Silva M, Callister ME, et al. False-Negative Results in Lung Cancer Screening-Evidence and Controversies. J Thorac Oncol. 2021. PMID: 33545386. doi:10.1016/j.jtho.2021.01.1607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。